Sedulo Group is a full-service competitive strategy consultancy offering a wide variety of competitive and market intelligence research-based services• Lead the cross functional, multinational Life Science Business Unit. Executive leadership team member• P&L responsibility including the development and execution of strategic growth initiatives, various executive management responsibilities, business development, and marketing functions

Built and led expert team responsible for curating and translating business analytics, decision science and competitive intelligence into actionable insights and recommendations supporting business operations and planning processes for a €5.5b leading consumer health care company. • Provide insights on commercial opportunities and risks based on synthesis of outside-in competitor views, disparate data translation, analytics, and macro-trend implications.• Created and launched data capability including data systems, governance, dashboarding and ad hoc tools deployment and training, resulting in a more efficient, empowered commercial user group with improved decision-making speed and outcomes.• Manage and collaborate with a broad ecosystem of internal (Commercial, M&A, Strategy, R&D/Innovation, Investor Relations, Digital) and external (supplier partnerships, industry experts) customers, optimizing Bayer CH’s commercial operations effectiveness and team’s impact.

Nestlé - Wyeth Nutrition acquired Pfizer Nutrition in December 2012

Built and led $2b+ nutritional business unit’s best-in-class market research, data & analytics, competitive intelligence, forecasting and global sales & operations planning capabilities. Provided analysis and fact-based recommendations in key strategic and tactical areas based on performance versus competition, current portfolio opportunities, consumer & competitor insights, and new product opportunities. • Led global strategic plan development guiding resource allocation in growth vs. stabilized markets, identified key growth drivers across nutrition segments, and defined market scope. Results: focused commercial and R&D activity, double-digit sales growth with improved margin, significantly increased product launch rate, and improved freshness index from below 10 percent to 30 percent. • Launched market data platform harmonizing disparate sources across markets, enabling better and more timely decision making. Recognized as best-in-class and adopted globally by Nestle Nutrition.• Essential to work team that developed CIM, resulting in divesting business to Nestle for $11.85b – 2.4x the $5b valuation just 30 months prior (October 2009 analyst estimate at Pfizer acquisition of Wyeth).• Leadership effectiveness: scored multiple times in top quartile benchmark in Pfizer management effectiveness index as rated by direct reports and management.

First Insights Partner at Wyeth, filling a role created as part of Wyeth’s company-wide “Marketing Excellence” commercial organization capabilities development and re-structuring. Integrated market research, analytics, payer insights and competitive intelligence to provide comprehensive understanding of rheumatology and dermatology biologic markets, developing insights and recommendations to drive growth for the $5b+ Enbrel® business. • Partnering with brand leadership, developed and refined strategies by integrating findings from promotional mix, patient flow modeling, segmentation, ethnography research, DTC analytics and landscape assessments, leading to prioritization of brand objectives. • Quantified~$100mm lost opportunity impact of Rx abandonment and uncovered related customer barriers to treatment, leading to recommendation and implementation of point-of-service solution.• Advanced partnership with Amgen in co-promotion.

Managed marketing operations for OrthoNeutrogena, a Johnson & Johnson specialty pharmaceutical company, including P&L responsibility, formulating long- and short-range strategic plans, product management, product launch teams, portfolio management, pricing, forecasting and market research. Management board member.

SANOFI - AVENTIS (Legacy Aventis, Rhone-Poulenc Rorer, Rorer, Dermik) 15 years of progressive, diversified experience in brand management, operations, sales and finance in both business unit and enabling functions at Sanofi-Aventis and its legacy companies:- Director of US Marketing, Dermik Laboratories, Berwyn PA (2002-2004) - Global Director - eBusiness, Aventis e-Business Group, Bridgewater, NJ (2000-2002)- Product Manager to Senior Product Manager to Group Product Manager, Dermik, Collegeville, PA (1996 - 2000)- Sales Operations Manager, Dermik, Collegeville, PA (1994-1996) - Sales Representative, Dermik, Los Angeles, CA (1993-1994)- Senior Financial Analyst to Treasury Supervisor, Rorer/RPR, Collegeville, PA (1989-1993)Accomplishments: • Led 3 therapeutic areas (Acne - Benzaclin®, Onychomycosis - Penlac®, Skin Cancer - Carac®), founding cross-functional teams that maximized sales and profits while improving the brand management and planning processes as Director of Marketing for Dermik• Matched e-technologies with viable business models (i.e., 2-way video selling, web collaboration) to enhance Aventis selling global opportunities with health care providers as Global Director - eBusiness• Increased Benzamycin® prescriptions by 23% and sales by 41% in 1999 with product repositioning and multi-channel campaign• Product Launch Experience: Launched Noritate®, a topical rosacea product, in U.S. (Jan 1998). Launch team leader for 3 products (Benzaclin®, Carac®, Noritate®)• Implemented computer-based call system, managing cultural change from paper-based system while improving customer targeting, reach and frequency as Sales Operations Manager• Ranked #3 out of 54 sales representatives with 121% quota attainment